Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Jul 15, 2026; 18(7): 120469
Published online Jul 15, 2026. doi: 10.4251/wjgo.120469
Published online Jul 15, 2026. doi: 10.4251/wjgo.120469
Table 3 Multivariable Cox regression analysis of recurrence-free survival, cancer-specific survival and overall survival in intrahepatic cholangiocarcinoma
| Variables | Recurrence-free survival | Cancer-specific survival | Overall survival | |||
| HR (95%CI) | P value | HR (95%CI) | P value | HR (95%CI) | P value | |
| Neoadjuvant therapy (no = 1) | 5.346 (1.737-16.455) | 0.003 | ||||
| LVI (no = 1) | 3.749 (1.895-7.418) | < 0.001 | 5.524 (2.600-11.738) | < 0.001 | ||
| Hemoglobin, g/L (≤ 12 = 1) | 0.438 (0.222-0.867) | 0.018 | 0.078 (0.013-0.486) | 0.006 | ||
| N category (pN0 = 1) | 3.562 (1.802-7.041) | < 0.001 | ||||
| rs10740055 (CC/CA = 1) | 2.413 (1.311-4.440) | 0.005 | 2.265 (1.137-4.513) | 0.020 | 4.095 (1.966-8.529) | < 0.001 |
- Citation: Wang G, Otto C, Liu D, Al-Masri TM, Lueong SS, Siveke J, Luedde T, Heise D, Vondran FW, Meister FA, Lurje G, Neumann U, Heij L, Bednarsch J. Prognostic significance of germline ARID5B and LEPR polymorphisms in intrahepatic and perihilar cholangiocarcinoma after curative resection. World J Gastrointest Oncol 2026; 18(7): 120469
- URL: https://www.wjgnet.com/1948-5204/full/v18/i7/120469.htm
- DOI: https://dx.doi.org/10.4251/wjgo.120469